Joseph Italiano/LinkedIn
Nov 20, 2025, 18:20
Joseph Italiano: Join Us to Pursue Cutting-Edge Research at the Interface of Megakaryocyte Biology
Joseph Italiano, Associate Professor Harvard Medical School, shared on LinkedIn:
”Join us to pursue cutting-edge research at the interface of megakaryocyte biology and translational medicine.
We have NIH-funded postdoctoral positions available to investigate platelet production and the broader functions of megakaryocytes.
I’ll be attending ASH and would be happy to connect if you’re interested.”
Stay updated with Hemostasis Today.
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition
-
Apr 12, 2026, 14:18Jean Jacques Kiladjian: Grateful to the MSH for the invitation to ‘Highlights of ASH’ in Asia-Pacific 2026
-
Apr 12, 2026, 14:15Paritosh Garg: A fibrotic marrow is not always PMF
-
Apr 12, 2026, 14:13Scott Woller: ACC/AHA Guidelines and the Role of Pulmonary Embolism Response Teams
-
Apr 12, 2026, 13:55Ifeanyichukwu Ifechidere: When Fibrinogen isn’t Really Fibrinogen
-
Apr 12, 2026, 13:53Alan Nurden: A Contemporary Update on the Pathogenesis of Inherited Platelet Dysfunction
-
Apr 12, 2026, 13:47Kalyan Roy: Visual Inspection of Blood Bags and Blood Products
-
Apr 12, 2026, 13:44Francisco Ujueta: PAD VS CAD – Why Individualized Antithrombotic Strategies Matter
-
Apr 12, 2026, 13:42William Aird: Anemia of Inflammation Not Just a Trade-Off but a Possible Compensation